{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:16:56Z","timestamp":1761005816118,"version":"build-2065373602"},"reference-count":25,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","strokejournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Stroke and Cerebrovascular Diseases"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.jstrokecerebrovasdis.2017.01.006","type":"journal-article","created":{"date-parts":[[2017,2,8]],"date-time":"2017-02-08T14:00:44Z","timestamp":1486562444000},"page":"1197-1203","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Epidemiology of Acquired Immune Deficiency Syndrome and Cerebrovascular Disease in a Post Antiretroviral Era"],"prefix":"10.1016","volume":"26","author":[{"given":"Phillip","family":"Kucab","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pratik","family":"Bhattacharya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jstrokecerebrovasdis.2017.01.006_bib0010","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1111\/j.1538-7836.2006.02047.x","article-title":"Absolute risk of venous and arterial thrombosis in HIV-infected patients and effects of combination antiretroviral therapy","volume":"4","author":"Lijfering","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jstrokecerebrovasdis.2017.01.006_bib0015","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1212\/01.wnl.0000259515.45579.1e","article-title":"Mechanisms of ischemic stroke in HIV-infected patients","volume":"68","author":"Ortiz","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.jstrokecerebrovasdis.2017.01.006_bib0020","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1136\/jnnp.2007.116103","article-title":"Stroke in patients with human immunodeficiency virus infection","volume":"78","author":"Tipping","year":"2007","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jstrokecerebrovasdis.2017.01.006_bib0025","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/QAI.0b013e31817bbbf0","article-title":"Antiretroviral therapy is associated with an atherogenic lipoprotein phenotype among HIV-1-infected men in the Multicenter AIDS Cohort Study","volume":"48","author":"Riddler","year":"2008","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.jstrokecerebrovasdis.2017.01.006_bib0030","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1056\/NEJM199512143332401","article-title":"Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group","volume":"333","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jstrokecerebrovasdis.2017.01.006_bib0035","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1161\/STROKEAHA.111.640060","article-title":"Intravenous thrombolysis for stroke increases over time at primary stroke centers","volume":"43","author":"Prabhakaran","year":"2012","journal-title":"Stroke"},{"key":"10.1016\/j.jstrokecerebrovasdis.2017.01.006_bib0040","doi-asserted-by":"crossref","first-page":"3102","DOI":"10.1001\/jama.283.23.3102","article-title":"Recommendations for the establishment of primary stroke centers. Brain Attack Coalition","volume":"283","author":"Alberts","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.jstrokecerebrovasdis.2017.01.006_bib0045","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1056\/NEJMoa0804656","article-title":"Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke","volume":"359","author":"Hacke","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jstrokecerebrovasdis.2017.01.006_bib0050","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/S0140-6736(95)90699-1","article-title":"Safety and activity of saquinavir in HIV infection","volume":"345","author":"Kitchen","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.jstrokecerebrovasdis.2017.01.006_bib0055","first-page":"39","article-title":"FDA approves OraQuick for use in saliva. On March 25, the FDA approved the first rapid test for HIV in oral fluids","volume":"16","author":"Branson","year":"2004","journal-title":"AIDS Clin Care"},{"key":"10.1016\/j.jstrokecerebrovasdis.2017.01.006_bib0060","first-page":"108","article-title":"Ryan White CARE Act Title IV programs: a preliminary characterization of benefits and costs","volume":"20","author":"Abramowitz","year":"2005","journal-title":"AIDS Public Policy J"},{"key":"10.1016\/j.jstrokecerebrovasdis.2017.01.006_bib0065","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1056\/NEJMoa051871","article-title":"Tenofovir DF, emtricitabine, and efavirenz vs. zidovudine, lamivudine, and efavirenz for HIV","volume":"354","author":"Gallant","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jstrokecerebrovasdis.2017.01.006_bib0070","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1212\/WNL.0b013e31820a0cfc","article-title":"Increasing incidence of ischemic stroke in patients with HIV infection","volume":"76","author":"Ovbiagele","year":"2011","journal-title":"Neurology"},{"issue":"Suppl 3","key":"10.1016\/j.jstrokecerebrovasdis.2017.01.006_bib0075","doi-asserted-by":"crossref","first-page":"S237","DOI":"10.1007\/s10461-013-0566-1","article-title":"Trends in HIV prevalence and HIV testing among young MSM: five United States cities, 1994-2011","volume":"18","author":"Oster","year":"2014","journal-title":"AIDS Behav"},{"key":"10.1016\/j.jstrokecerebrovasdis.2017.01.006_bib0080","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0140-6736(08)61113-7","article-title":"Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies","volume":"372","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.jstrokecerebrovasdis.2017.01.006_bib0085","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1086\/605578","article-title":"Relationship between inflammatory markers, endothelial activation markers, and carotid intima-media thickness in HIV-infected patients receiving antiretroviral therapy","volume":"49","author":"Ross","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jstrokecerebrovasdis.2017.01.006_bib0090","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1097\/00002030-200311210-00010","article-title":"Increased risk of myocardial infarction with duration of protease inhibitor therapy in HIV-infected men","volume":"17","author":"Mary-Krause","year":"2003","journal-title":"AIDS"},{"key":"10.1016\/j.jstrokecerebrovasdis.2017.01.006_bib0095","first-page":"49","article-title":"Dyslipidemia related to antiretroviral therapy","volume":"13","author":"Estrada","year":"2011","journal-title":"AIDS Rev"},{"key":"10.1016\/j.jstrokecerebrovasdis.2017.01.006_bib0100","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1212\/WNL.0b013e318270401d","article-title":"Age at stroke: temporal trends in stroke incidence in a large, biracial population","volume":"79","author":"Kissela","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.jstrokecerebrovasdis.2017.01.006_bib0105","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1097\/QAD.0000000000000452","article-title":"Effect of CD4+ cell count and viral suppression on risk of ischemic stroke in HIV infection","volume":"28","author":"Chow","year":"2014","journal-title":"AIDS"},{"key":"10.1016\/j.jstrokecerebrovasdis.2017.01.006_bib0110","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1097\/COH.0000000000000072","article-title":"HIV and aging: emerging research issues","volume":"9","author":"Hunt","year":"2014","journal-title":"Curr Opin HIV AIDS"},{"year":"2014","series-title":"Mortality in the United States, 2013","author":"Kochanek","key":"10.1016\/j.jstrokecerebrovasdis.2017.01.006_bib0115"},{"key":"10.1016\/j.jstrokecerebrovasdis.2017.01.006_bib0120","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.2105\/AJPH.2009.170241","article-title":"Examination of inequalities in HIV\/AIDS mortality in the United States from a fundamental cause perspective","volume":"100","author":"Rubin","year":"2010","journal-title":"Am J Public Health"},{"key":"10.1016\/j.jstrokecerebrovasdis.2017.01.006_bib0125","doi-asserted-by":"crossref","first-page":"657961","DOI":"10.1155\/2013\/657961","article-title":"Widening socioeconomic, racial, and geographic disparities in HIV\/AIDS mortality in the United States, 1987-2011","volume":"2013","author":"Singh","year":"2013","journal-title":"Adv Prev Med"},{"key":"10.1016\/j.jstrokecerebrovasdis.2017.01.006_bib0130","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1212\/WNL.0000000000000237","article-title":"A decade of racial and ethnic stroke disparities in the United States","volume":"82","author":"Gutierrez","year":"2014","journal-title":"Neurology"}],"container-title":["Journal of Stroke and Cerebrovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1052305717300095?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1052305717300095?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T06:38:58Z","timestamp":1760942338000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1052305717300095"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["S1052305717300095"],"URL":"https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2017.01.006","relation":{},"ISSN":["1052-3057"],"issn-type":[{"type":"print","value":"1052-3057"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epidemiology of Acquired Immune Deficiency Syndrome and Cerebrovascular Disease in a Post Antiretroviral Era","name":"articletitle","label":"Article Title"},{"value":"Journal of Stroke and Cerebrovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2017.01.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 National Stroke Association. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}